Literature DB >> 18577287

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.

Arto Nordlund1, Sindre Rolstad, Ola Klang, Karin Lind, Mona Pedersen, Kaj Blennow, Ake Edman, Stefan Hansen, Anders Wallin.   

Abstract

UNLABELLED: Mild cognitive impairment (MCI) is regarded as the prodromal stage of dementia disorders, such as Alzheimer's disease (AD).
OBJECTIVE: To compare the neuropsychological profiles of MCI subjects with normal concentrations of total tau (T-tau) and Abeta42 in CSF (MCI-norm) to MCI subjects with deviating concentrations of the biomarkers (MCI-dev). MCI-norm (N = 73) and MCI-dev (N = 73) subjects were compared to normal controls (N = 50) on tests of speed/attention, memory, visuospatial function, language and executive function.
RESULTS: MCI-norm performed overall better than MCI-dev, specifically on tests of speed and attention and episodic memory. When MCI-dev subjects were subclassified into those with only high T-tau (MCI-tau), only low Abeta42 (MCI-Abeta) and both high T-tau and low Abeta42 (MCI-tauAbeta), MCI-tauAbeta tended to perform slightly worse. MCI-tau and MCI-Abeta performed quite similarly.
CONCLUSIONS: Considering the neuropsychological differences, many MCI-norm probably had more benign forms of MCI, or early non-AD forms of neurodegenerative disorders. Although most MCI-dev performed clearly worse than MCI-norm on the neuropsychological battery, some did not show any deficits when compared to age norms. A combination of CSF analyses and neuropsychology could be a step toward a more exact diagnosis of MCI as prodromal AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577287     DOI: 10.1017/S135561770808079X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  12 in total

1.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.

Authors:  Charles B Malpas; Michael M Saling; Dennis Velakoulis; Patricia Desmond; Terence J O'Brien
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment.

Authors:  Ozioma C Okonkwo; Michelle M Mielke; H Randall Griffith; Abhay R Moghekar; Richard J O'Brien; Leslie M Shaw; John Q Trojanowski; Marilyn S Albert
Journal:  Arch Neurol       Date:  2011-01

Review 4.  Should mild cognitive impairment be subtyped?

Authors:  Tiffany F Hughes; Beth E Snitz; Mary Ganguli
Journal:  Curr Opin Psychiatry       Date:  2011-05       Impact factor: 4.741

Review 5.  Beta-amyloid deposition and the aging brain.

Authors:  Karen M Rodrigue; Kristen M Kennedy; Denise C Park
Journal:  Neuropsychol Rev       Date:  2009-11-12       Impact factor: 7.444

6.  The utility of intraindividual variability in selective attention tasks as an early marker for Alzheimer's disease.

Authors:  Janet M Duchek; David A Balota; Chi-Shing Tse; David M Holtzman; Anne M Fagan; Alison M Goate
Journal:  Neuropsychology       Date:  2009-11       Impact factor: 3.295

7.  Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology.

Authors:  Mark W Bondi; Glenn E Smith
Journal:  J Int Neuropsychol Soc       Date:  2014-02-04       Impact factor: 2.892

8.  Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.

Authors:  Chera L Maarouf; Tracy M Andacht; Tyler A Kokjohn; Eduardo M Castaño; Lucia I Sue; Thomas G Beach; Alex E Roher
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

9.  Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study.

Authors:  Anna Grahn; Staffan Nilsson; Arto Nordlund; Thomas Lindén; Marie Studahl
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 6.682

Review 10.  Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.